LabGenius Therapeutics Company Profile, Contacts & Intelligence
LabGenius Therapeutics Overview
LabGenius Therapeutics ("LabGenius") is a drug discovery company pioneering the discovery of next-generation therapeutic antibodies. The company’s discovery platform, EVA™, integrates several cutting-edge technologies drawn from the fields of artificial intelligence, robotic automation and synthetic biology. While EVA™ is both modality and format-agnostic, LabGenius' internal pipeline is focussed on the development of selectivity-enhanced antibodies for the treatment of solid tumours. The company's novel approach is delivering a pipeline of antibody therapeutics with best-in-class killing profiles.
- Headquarters
- London, City of, United Kingdom
- Website
- www.labgeniustx.com
- Industry
- Biotechnology Research
- Founded
- 2012
- NAICS
- Research and Development in Biotechnology (except Nanobiotechnology)
LabGenius Therapeutics Contact Intelligence
See which contact channels and departments are represented in the visible AeroLeads data.
LabGenius Therapeutics People & Org Chart Preview
Sample people records show job titles and whether email or phone data is available without exposing raw contact details.
LabGenius Therapeutics Workforce Composition
Seniority breakdown across 3 visible profiles.
Compare Similar Companies to LabGenius Therapeutics
Explore companies in related markets and compare their industry and employee estimates.
| Company | Industry / match | Employee estimate | Page |
|---|---|---|---|
| Isomorphic Labs | Biotechnology Research | 246 | View company |
| BenevolentAI | Software Development | 81 | View company |
| Exscientia | Biotechnology Research | 71 | View company |
| Healx | Biotechnology Research | 68 | View company |
| Bactobio | Biotechnology Research | 59 | View company |
| Basecamp Research | Biotechnology Research | 55 | View company |
| Hoxton Farms | Biotechnology Research | 52 | View company |
| Synthace | Biotechnology Research | 40 | View company |
| Multus | Biotechnology Research | 27 | View company |
| Uncommon | Biotechnology Research | 27 | View company |